Gene Biotherapeutics Inc.

Industry

  • Pharmaceuticals
    • Vaccines
  • Digital Health
    • Disease Management
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule

Other Names/Subsidiaries

  • Angionetics Inc.
  • Cardium Therapeutics, Inc.
  • Shanxi Taxus Pharmaceuticals Co., Ltd.
  • Shenzhen Forntsea Taxus Industry Capital Management
  • Taxus Cardium Pharmaceuticals Group
  • Activation Therapeutics
  • Life Again Insurance Solutions
  • Post-Hypothermia Corporation
  • Tissue Repair
See more in Biomedtracker

Latest on Gene Biotherapeutics Inc.

Pink Sheet

Keeping Track: FDA Approves First Rx DHEA, Receives Applications For Midostaurin, Gesulkumab, Biosimilar Avastin

 
• By Bridget Silverman

FDA turned down two more novel agents this week, with complete response letters announced for Dynavax Technologies Corp. 's hepatitis B vaccine Heplisav-B and Spectrum Pharmaceuticals Inc. 's

In Vivo

Deals Shaping the Medical Industry, August 2016

 
• By Beth Allan, Deanna Kamienski, Amanda Micklus, Steven Muntner, and Maureen Riordan

IN VITRO DIAGNOSTICS Alliances Cleveland HeartLab LLC Global Discovery Biosciences Global Discovery Biosciences licensed Cleveland HeartLab Inc. exclusive rights to distribute its PULS ( Prote

Scrip

Venture Funding Deals, August 2016

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Steven Muntner, and Maureen Riordan

Alcresta Inc. Alcresta brings in $49.4m via Series C Alcresta Inc. (therapies for gastrointestinal disorders and rare diseases) raised $49.4m in its Series C financing to new backer Athyrium a

Scrip

Huapont Taps US Partner To Ride China Precision Medicine Wave

 
• By Ying Huang

China-listed Huapont Life Sciences Co. Ltd. has inked an exclusive territorial distribution and license agreement with US strategic partner Angionetics Inc. to develop in China a gene therapy